Tilray Brands Inc (TLRY)
1.415
+0.08
(+5.60%)
USD |
NASDAQ |
Nov 25, 16:00
1.42
0.00 (0.00%)
After-Hours: 19:41
Tilray Brands Revenue (TTM): 812.04M for Aug. 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
August 31, 2024 | 812.04M |
May 31, 2024 | 788.94M |
February 29, 2024 | 743.25M |
November 30, 2023 | 700.50M |
August 31, 2023 | 650.86M |
May 31, 2023 | 627.12M |
February 28, 2023 | 596.26M |
November 30, 2022 | 602.54M |
August 31, 2022 | 613.56M |
May 31, 2022 | 628.37M |
February 28, 2022 | 617.28M |
November 30, 2021 | 589.31M |
August 31, 2021 | 563.62M |
May 31, 2021 | 513.08M |
February 28, 2021 | 484.22M |
November 30, 2020 | 468.12M |
August 31, 2020 | 429.41M |
May 31, 2020 | 406.28M |
Date | Value |
---|---|
February 29, 2020 | 389.66M |
November 30, 2019 | 337.82M |
August 31, 2019 | 263.39M |
May 31, 2019 | 179.26M |
February 28, 2019 | 91.67M |
November 30, 2018 | 43.74M |
August 31, 2018 | 34.02M |
May 31, 2018 | 28.64M |
February 28, 2018 | 23.50M |
November 30, 2017 | 19.35M |
August 31, 2017 | 16.63M |
May 31, 2017 | 15.12M |
February 28, 2017 | 13.41M |
November 30, 2016 | 11.50M |
August 31, 2016 | 9.127M |
May 31, 2016 | 6.503M |
February 29, 2016 | 4.614M |
November 30, 2015 | 2.678M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
337.82M
Minimum
Nov 2019
812.04M
Maximum
Aug 2024
578.11M
Average
599.40M
Median
Revenue (TTM) Benchmarks
Aurinia Pharmaceuticals Inc | 220.36M |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | 0.411M |
Xenon Pharmaceuticals Inc | -- |
ESSA Pharma Inc | -- |